---
title: "Wedge Industrial Co., Ltd. (000534.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000534.SZ.md"
symbol: "000534.SZ"
name: "Wedge Industrial Co., Ltd."
industry: "Biotechnology"
datetime: "2026-05-21T16:51:05.915Z"
locales:
  - [en](https://longbridge.com/en/quote/000534.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000534.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000534.SZ.md)
---

# Wedge Industrial Co., Ltd. (000534.SZ)

## Company Overview

Wedge Industrial Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China. The company offers micro-ecological preparations, such as bifidobacterium lactobacillus triple live bacteria tablets under the Golden Bifidobacterium brand; vaginal lactobacillus live capsules under the Dingjunsheng brand; dual-span microecological live bacteria drugs under the Jinshuangqi brand; and vaginal microecological live bacteria drug for use in the treatment of gynecological infections under the Dingjunsheng brand. It also provides probiotic products, health food products, probiotic dietary supplements, probiotic hand creams, and other probiotic health products under the Sanlian Probiotics, Bacteria powder, and Today's Bacteria brands. In addition, the company is involved in the research, development, and manufacture of high-temperature alloy materials and core components, including precision casting blades, high temperature alloy powder discs, high temperature master alloys and their alloy powders, and nickel-based high-temperature master alloys.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | CN Market |
| Website | [www.wedgeind.com](https://www.wedgeind.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: C (0.45)**

**Industry**: Biotechnology

| Metric | Value |
|--------|-------|
| Industry Ranking | 28 / 81 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 17.08% |  |
| Net Profit YoY | 1.07% |  |
| P/B Ratio | 10.96 |  |
| Dividend Ratio | 0.13% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 18796708766.19 |  |
| Revenue | 1312717779.18 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 12.58% | B |
| Profit Margin | 15.34% | A |
| Gross Margin | 71.11% | A |
| Revenue YoY | 17.08% | B |
| Net Profit YoY | 1.07% | C |
| Total Assets YoY | 31.87% | A |
| Net Assets YoY | 14.25% | B |
| Cash Flow Margin | 54.74% | C |
| OCF YoY | 17.08% | B |
| Turnover | 0.28 | D |
| Gearing Ratio | 64.38% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Wedge Industrial Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "17.08%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "1.07%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "10.96",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.13%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "18796708766.19",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1312717779.18",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "12.58%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "15.34%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "71.11%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "17.08%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "1.07%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "31.87%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "14.25%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "54.74%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "17.08%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.28",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "64.38%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 90.30 | 32/81 | 85.32 | 47.06 | 36.90 |
| PB | 10.61 | 68/81 | 11.53 | 6.72 | 5.05 |
| PS (TTM) | 13.85 | 61/81 | 14.74 | 8.48 | 6.57 |
| Dividend Yield | 0.13% | 38/81 | 0.77% | 0.23% | 0.13% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Sunshine Guojian Pharmaceutical (688336.SH) | A | A | B | A | B | A |
| 02 | AMOYTOP (688278.SH) | A | A | A | A | B | A |
| 03 | BeOne Medicines (688235.SH) | B | A | B | C | A | B |
| 04 | RemeGen (688331.SH) | A | A | C | C | B | B |
| 05 | Biocytogen (688796.SH) | A | A | E | B | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-29T16:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Overweight | 1 | 50% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 14.84 |
| Highest Target | 24.00 |
| Lowest Target | 24.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/000534.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/000534.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/000534.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/000534.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**